NEKTAR THERAPEUTICS Quarterly Unrecognized Tax Benefits in USD from Q4 2010 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of unrecognized tax benefits.
Summary
Nektar Therapeutics quarterly Unrecognized Tax Benefits history and growth rate from Q4 2010 to Q4 2023.
  • Nektar Therapeutics Unrecognized Tax Benefits for the quarter ending December 31, 2023 was $126M, a 47.4% increase year-over-year.
Unrecognized Tax Benefits, Quarterly (USD)
Unrecognized Tax Benefits, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $126M +$40.7M +47.4% Dec 31, 2023 10-K 2024-03-05
Q4 2022 $85.8M +$5.24M +6.5% Dec 31, 2022 10-K 2024-03-05
Q4 2021 $80.6M +$1.94M +2.47% Dec 31, 2021 10-K 2024-03-05
Q4 2020 $78.7M +$1.26M +1.62% Dec 31, 2020 10-K 2024-03-05
Q4 2019 $77.4M +$50M +182% Dec 31, 2019 10-K 2023-02-28
Q4 2018 $27.4M +$6.94M +33.9% Dec 31, 2018 10-K 2022-03-01
Q4 2017 $20.5M +$2.07M +11.2% Dec 31, 2017 10-K 2021-02-26
Q4 2016 $18.4M +$1.03M +5.92% Dec 31, 2016 10-K 2020-02-28
Q4 2015 $17.4M -$10.1M -36.8% Dec 31, 2015 10-K 2019-03-01
Q4 2014 $27.5M +$11.2M +68.2% Dec 31, 2014 10-K 2018-03-01
Q4 2013 $16.4M +$2.3M +16.3% Dec 31, 2013 10-K 2017-03-01
Q4 2012 $14.1M +$491K +3.62% Dec 31, 2012 10-K 2016-03-01
Q4 2011 $13.6M +$518K +3.97% Dec 31, 2011 10-K 2015-02-26
Q4 2010 $13.1M Dec 31, 2010 10-K 2014-02-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.